Drug General Information
Drug ID
D0SO5A
Former ID
DNC013291
Drug Name
ATC-120
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530533]
Structure
Download
2D MOL

3D MOL

Formula
C21H29N3O2S2
Canonical SMILES
CC(C1=CC=C(C=C1)NS(=O)(=O)C)NC(=S)NCC2=CC=C(C=C2)C(C)(C<br />)C
InChI
1S/C21H29N3O2S2/c1-15(17-8-12-19(13-9-17)24-28(5,25)26)23-20(27)22-14-16-6-10-18(11-7-16)21(2,3)4/h6-13,15,24H,14H2,1-5H3,(H2,22,23,27)/t15-/m1/s1
InChIKey
MRGDOZGZFFCDRJ-OAHLLOKOSA-N
PubChem Compound ID
Target and Pathway
Target(s) Vanilloid receptor Target Info Inhibitor [530533]
Vanilloid receptor 1 Target Info Inhibitor [530533]
KEGG Pathway Neuroactive ligand-receptor interaction
Inflammatory mediator regulation of TRP channels
NetPath Pathway IL2 Signaling Pathway
Pathway Interaction Database Trk receptor signaling mediated by the MAPK pathway
Trk receptor signaling mediated by PI3K and PLC-gamma
Reactome TRP channels
References
Ref 530533Bioorg Med Chem. 2010 Jan 1;18(1):111-6. Epub 2009 Nov 10.Silicon switch approach in TRPV1 antagonist MK-056 and its analogues.
Ref 530533Bioorg Med Chem. 2010 Jan 1;18(1):111-6. Epub 2009 Nov 10.Silicon switch approach in TRPV1 antagonist MK-056 and its analogues.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.